Alveolar echinococcosis;Échinococcose alvéolaire

EMC - Hepato-Gastroenterologie

Volumn 2, Issue 2, 2005, Pages 86-104

  Bresson Hadni, S ^a,b,c   Piarroux, R ^a,b,c   Bartholomot, B ^a   Miguet, J P ^a,c   Mantion, G ^a,c   Vuitton, D A ^a,b  

^a Ctr Collaborateur l'Organisation Mondiale S Pour Prev et Traitement Echinococcoses   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Alveolar echinococcosis; Benzimidazoles; Echinococcus multilocularis; Immunomodulation; Interventional radiology; Liver transplantation; Surgical resection

Indexed keywords

EID: 32044440211     PISSN: 17696763     EISSN: 17696763     Source Type: Journal    
DOI: 10.1016/j.emchg.2005.01.001     Document Type: Short Survey

References (73)

1. Algros MP, Majo P, Bresson-Hadni S, Koch S, Godard J, Cattin F, et al. Intracerebral alveolar echinococcosis. Infection 2003;31:63-5.
2. Ammann RW, Hoffmann AF, Grimm F, Eckert J. Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis. J Hepatol 1998;29:994-8.
3. Bret PM, Paliard P, Partensky C, Bretagnolle M, Blanchut P. Le traitement de la cholestase par sténoses des voies biliaires intrahépatiques au cours de l'échinococcose alvéolaire. Essai de drainage biliaire par voie percutanée transhépatique. Gastroentérol Clin Biol 1984;8:308-13.
4. Bresson-Hadni S, Bartholomot B, Miguet JP, Mantion G, Vuitton DA. L'échinococcose alvéolaire hépatique. Hepato-Gastro 1997;2:151-64.
5. Bresson-Hadni S, Franza A, Miguet JP, Vuitton DA, Lenys D, Monnet E, et al. Orthotopic liver transplantation for Incurable alveolar echlnococcosls of the liver: report of 17 cases. Hepatology 1991;13:1061-70.
6. Bresson-Hadni S, Humbert P, Palntaud G, Auer H, Lenys D, Lauvert R, et al. Skin localization of alveolar echinococcosis of the liver. J Am Acad Dermatol 1986;34:873-7.
7. Bresson-Hadni S, Koch S, Beurton I, Vuitton DA, Bartholomot B, Hrusovsky S, et al. Primary disease recurrence after liver transplantation for alveolar echlnococcosls: longterm evaluation In 15 patients. Hepatology 1999;30:857-64.
8. Bresson-Hadni S, Koch S, Miguet JP, Gillet M, Mantion GA, Heyd B, et al. Indications and results of liver transplantation for echinococcus alveolar Infection: an overview. Langenbecks Arch Surg 2003;388:231-8.
9. Bresson-Hadni S, Laplante JJ, Lenys D, Rohmer P, Gottstein B, Jacquier P, et al. Seroepidemiological screening of E. multilocularis infection in 7 884 subjects of a European endemic area of alveolar echinococcosis. Am J Trop Hyg 1994;51:837-46.
10. Bresson-Hadni S, Mantion G-A. Que reste-t-il du traitement chirurgical de l'échinococcose alvéolaire? Lettre Hépato- Gastroentérot 2001;3:118-23.
11. Bresson-Hadni S, Petitjean O, Monnot-Jacquard B, Heyd B, Kantelip B, Deschaseaux M, et al. Cellular localisations of interleukin-1β, interleukin-6 and tumor necrosis factor-α mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis. Eur Cytokine Netw 1994;5:461-8.
12. Bresson-Hadni S, Vuitton D-A. Echinococcoses. Rev Prat 2001;51:2091-8.
13. Bresson-Hadni S, Vuitton DA, Lenys D, Liance M, Racadot E, Miguet JP. Cellular immune response in Echinococcus multilocularis infection In humans. I: Lymphocytes reactivity to Echinococcus antigens in patients with alveolar echlnococcosls. Clin Exp Immunol 1989;78:61-6.
14. Bresson-Hadni S, Vuitton DA, Bartholomot B, Heyd B, Godard D, Meyer JP, et al. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 2000;12:327-36.
15. Bresson-Hadni S, Vuitton DA, Miguet JP, Rohmer P, Mantion G, Gillet M. L'échinococcose avéolalre hépatique. Encycl Méd Chir (Elsevier SAS, Paris), Hépatologle, 7-023-A-20, 1994: 9p.
16. Craig P. Echinococcus multilocularis. Curr Opin Infect Dis 2003;16:437-44.
17. Craig PS, Deshan L, MacPherson CN, Dazhong S, Reynolds D, Barnish G, et al. A large focus of alveolar echlnococcosls in central China. Lancet 1992;340:826-31.
18. Davis A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazole carbamates in human echinococcosis. Bull World Health Organ 1986;64:383-8.
19. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-D-deoxy glucose position emission tomography in clinical infectious diseases, Eur J Clin Microbiol Infect 2002;21:247-57.
20. Diebold-Berger S, Khan H, Gottstein N, Puget E, Frossard JL, Remadi S. Cytologic diagnosis of isolated pancreatic alveolar hydatid disease with immunologic and PCR analyses. A case report. Acta Cytol 1997;41:1381-6.
21. Eckert J, Deplazes P. Alveolar echinococcosis in humans: the current situation In central Europe and the need for counter measures. Parasital Today 1999;15:315-9.
22. Eckert J, Conraths F, Tackmann K. Echinococcosis: an emerging or re-emerging zoonosls? Int J Parasitol 2000;30: 1283-94.
23. Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Beurton I, Bresson-Hadni S, et al. HLA and alveolar echinococcosis. Tissue Antigens 1998;52:124-9.
24. Emery I, Liance M, Deriaud E, Vuitton DA, Houin R, Leclerc C. Characterization of T-cell Immune responses of Echinococcus multilocularis infected C57BL/6J mice. Parasite Immunol 1996;18:463-72.
25. Frossard JL, Amenian B, Gottstein B, Diebold-Berger S, Khan H, Vine R, et al. A case of alveolar echinococcosis restricted to the pancreas. Am J Gastroenterol 1997;92: 2117-9.
26. Gillet M, Bresson-Hadni S. L'échlnococcose alvéolaire hépatique. Rev Prat 1991;41:1805-11.
27. Giraudoux P, Raoul F, Bardonnet K. Alveolar echinococcosis: characterisation of a possible emergence and new perspective in epidemio-surveillance. Méd Mal Infect 2001;31:247-56.
28. Godot V, Harraga S, Tiberghien P, Sarciron E, Gottstein B, Vuitton DA. Resistance/susceptibility to Echinococcus multilocularis and cytoklne profile In humans. II. Influence of the HLA B8. DR3, DQ2 haplotype. Clin Exp Immunol 2000;121:491-8.
29. Godot V, Harrager S, Beurton I, Pater C, Sarciron ME, Gottstein B, et al. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I: Comparisons of patients with progressive and abortive lesions. Clin Exp Immunol 2000;121:484-90.
30. Godot V, Harraga S, Podoprigora, Liance M, Bardonnet K, Vuitton DA. IFNα-2a protect mice against a helminth infection In the liver and modulates immune responses. Castroenterology 2003;124:1441-50.
31. Gottstein B, Bettens F. Association between HLA-DR 13 and susceptibility to alveolar echinococcosis. J Infect Dis 1994; 169:1416-7.
32. Gottstein B, Jacquier P, Bresson-Hadni S, Eckert J. Improved primary immunodiagnosis of alveolar echlnococcosis In humans by an enzyme-linked immunosorbent assay using the Em2 plus antigen. J Clin Microbiol 1993;31: 373-6.
33. Gottstein B, Saucy F, Deplazes P, Reichen J, Demierre G, Busato A, et al. Is high prevalence of Echinococcus multilocularis in wild and domestic animals associated with disease incidence in humans? Emerg Infect Dis 2001;7:408-12.
34. Helbig M, Frosch P, Kern P, Frosch M. Serological differenciation between cystic and alveolar echinocococcosis by use of recombinant larval antigens. J Clin Microbiol 1993;31:3211-5.
35. Ishizu H, Uchino J, Sato N, Aoki S, Suzuki K, Kuribayashi H. Effect of albendazole on recurrent and residual alveolar echlnococcosis of the liver after surgery. Hepatotogy 1997;25:528-31.
36. Ito A, Schantz P, Wilson J. Em-18: a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease. Am J Trop Med Hyg 1995;52:41-6.
37. Jensens B, Reuter S, Kratzer W, Naser K, Kächele V, Kimmig P, et al. Long-term seroposltivity against Echinococcus multilocularis In an epidemiological follow-up study In southwestern Germany (Römerstein). Infection 2001;29:124-9.
38. Kern P, Bardonnet K, Rennet E. European Echinococcosis registring: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis 2003;9:343-9.
39. Koch S, Bresson-Hadni S, Mlguet JP, Crumbach JP, Gillet M, Mantlon GA, et al. Experience of liver transplantation for Incurable alveolar echinococcosis: a 45 case european collaborative report. Transplantation 2003;75:856-63.
40. Kodama Y, Fujita N, Shimizu T, Endo H, Nambu T, Sato N, et al. Alveolar echinococcosis: MR findings in the liver. Radiology 2003;228:172-7.
41. Liance M, Janin V, Bresson-Hadni S, Vuitton DA, Houin R, Piarroux R. Immunodiagnosis of Echinococcus infections: confirmatory testing and species differentiation by a new commercial Western Blot. J Clin Microbiol 2000;38:3718-21.
42. Magy N, Bresson-Hadni S, Auge B, Toussirot E, Wendling D. Polyarthritis accompanying alveolar echinococcosis or the icing on the cake? Rev Méd Interne 2000;21:460-1.
43. McManus D, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003;362:1295-304.
44. Miguet J-P, Bresson-Hadni S. Alveolar echinococcosis of the liver. J Hepatol 1989;8:373-9.
45. Petavy AF, Tenora F, Deblock S, Sergent V. Echinococcus multilocularis in domestic cats In France. A potential risk factor for alveolar hydatid disease contamination in humans. Vet Parasitol 2000;87:151-6.
46. Rausch RL, Wilson JF, Schantz PM, McMahon P. Spontaneous death of Echinococcus multilocularis: case diagnosed serologically (by Em2-Elisa) and clinical significance. Am J Trop Med Hyg 1987;36:576-85.
47. Reuter S, Buck A, Grebe O, Nüssle-Kügele K, Kern P, Manfras BJ. Salvage treatment with amphotericln B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 2003;47:3586-91.
48. Reuter S, Bück A, Manfras S, Kratzer W, Seitz HM, Darge K, et al. Structured treatment Interruption in patients with alveolar echinococcosis. Hepatology 2004;39:509-17.
49. Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 2000;46:451-6.
50. Reuter S, Nüssle K, Kolokythas O, Hang U, Rieber H, Kern P, et al. Alveolar liver echinococcosis: a comparative study of three Imaging techniques. Infection 2001;29:119-25.
51. Reuter S, Schirrneister H, Kratzer W, Dreweck C, Reske SN, Kern P. Pericystic metabolic activity In alveolar echinococcosis: assessment and follow-up by Position Emission Tomography. Clin Infect Dis 1999;29:1157-63.
52. Reuter S, Seitz HM, Kern P, Junghanss T. Extrahepatic alveolar echinococcosis without liver Involvement: a rare manifestation. Infection 2000;28:187-92.
53. Ricard-Blum S, Bresson-Hadni S, Guerret S, Grenard P, Volle VJ, Risteli L. Mechanism of collagen network stabilization In human irreversible granulomatous liver flbrosis. Gastroenterology 1996;111:172-82.
54. Ricard-Blum S, Bresson-Hadni S, Vuitton DA, Ville G, Grimaud JA. Hydroxypyridinium Collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology 1992;15:599-602.
55. Romig T, Bilger B, Dinkel A, Merli M, Mackenstedt U. Echinococcus multilocularis in animal hosts: new data from Western Europe. Helminthologia 1999;36:185-91.
56. Romig T, Kratzer W, Kimmig P, Frosch M, Gaus W, Flegel WA, et al. An epidemiologic survey of human alveolar echinococcosis In southwestern Germany. Am J Trop Med Hyg 1999;61:566-73.
57. Sarciron E, Bresson-Hadni S, Mercier M, Lawton P, Duranton C, Lenys D, et al. Antibodies against Echinococcosus multilocularis alkaline phosphatase as markers for the specific diagnosis and the serological monitoring of alveolar echinococcosis. Parasite Immunol 1997;19:61-8.
58. Siles-Lucas MM, Gottstein B. Molecular tools for the diagnosis of cystic and alveolar echinococcosis. Trop Med Int Health 2001;6:463-75.
59. Sitruck L. Echinococcose alvéolaire. L'homme prend la place du rongeur. FMC Parasitologle. Le Généraliste 2002;2170:10-4.
60. Stumpe KD, Dazzi H, Schaffner A, Von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27:822-32.
61. Stumpe KD, Renner-Schneiter EC, Grimm F, Kadry Z, Deplazes P, Clavien PA, et al. Does fluorodeoxyglucose Positron-Emission Tomography (FDG-PET) of Echinococcus multilocularis (EM) liver lesions reflect parasite vitality? Eur J Nucl Med 2003;30(suppl2):S196-226.
62. Sturm D, Menzel J, Gottstein B, Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 1995:63:1688-97.
63. Tsukarla H, Morishima Y, Nonaka W, Oku Y, Komiya M. Preliminary study of the role of red foxes in Echinococcus multitocularis transmission in the urban area of Sapporo, Japan. Parasitology 2000;120:423-8.
64. Vellinghausen N, Gebert P, Kern P. Interleukln (IL)-4, IL-10 and Il-12 profile in serum of patients with alveolar echinococcosis. Acta Trop 1999;73:165-74.
65. Vogel J, Gorich J, Kramme E, Merkle E, Sokiranski R, Kern P, et al. Alveolar echinococcosis of the liver: percutaneous stent therapy in Budd-Chiari syndrome. Gut 1996;39:762-4.
66. Vuitton DA, Bresson-HadnI S, Laroche L, Kaiserlian D, Guerret-Stocker S, Bresson JL, et al. Cellular immune response In Echinococcus multilocularis Infection in humans: 2) natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol 1989;78:67-74.
67. Vuitton DA, Bresson-Hadni S, Liance M, Meyer JP, Giraudoux P, Lenys D, et al. L'échinococcose alvéolaire humaine. Hasard épidémiologique ou fatalité immunologlque? Gastroentérol Clin Biol 1990;14:124-30.
68. Vuitton DA, Godot V, Zhang S, Harraga S, Penfornls A, Beurton I, et al. Host immunogenetics and role in: epidemiology of larval cestodoses. In: Craig P, Pawlowski Z, editors. Cestode zoonose: echinococcosts and cysttcercosis. Washington DC: IOS Press; 2002.
69. Vuitton DA, Zhou H, Bresson-Hadni S, Wang Q, Piarroux M, Raoul F, et al. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology 2003;127(suppl):S87-S107.
70. Wang X, Liu Y, Yu D. Continuous therapy with albendazole for hepatic alveolar echinococcosis associated with obstructive jaundice. Clin J Intern Med 1996;35:261-4.
71. Watelet J, Bresson-Hadni S, Guillemln F, Sauv́ G, Beurton I, Bronowicki JP. Comparison of surgery and chemotherapy In alveolar echlnococcosls. J Hepatol 2002; 36(suppl1):596.
72. Wellinghausen N, Gebert P, Kern P. Interleukin (IL)-4, Il-10 and IL-12 profile in serum of patients with alveolar echlnococcosls. Acta Trop 1999;73:165-74.
73. WHO informal Working Group on Echlnococcosls. Guidelines for treatment of cystic and alveolar echinococcosis In humans. Bull World Health Organ 1996;74:231-42.